Impact Dashboard - October 2014

Transcription

1 Impact Dashboard By 2014, PSI and its network members averted an estimated 44.2 million DALYs globally. PSI has met 60.6% of the strategic plan (SP) target to avert million DALYs, and 56.4% of the SP target to provide million CYPs; with 56.7% elapsed time. 12 African countries have averted > 1 million DALYs in 2014, accounting for 88% YTD total, see page 3. As a region, West & Central Africa has doubled DALYs averted relative to YTD Malaria DALYs averted have also doubled. In, Malaria accounted for 68% of DALYs averted with the distribution of LLINs in Zimbabwe, South Sudan, Mali and ACTs in Congo-Kinshasa, Mali, and Nigeria. By far, our biggest CYP producers are Nigeria, Kenya, Pakistan, Tanzania, and South Africa; total of 53% of YTD CYPs and each accounted for > 1 million CYPs, see page 5. PSI PROGRESS ON SCALE SP to date SP Target % SP Target 5,029,385 44,186,471 41% 120,479, ,700, % CYPs 1,559,152 16,001,809-15% 59,560, ,600, % PSI Health Relevance 24.91% PSI Burden 2.25% PSI PROGRESS TOWARD STRATEGIC PLAN (SP) TARGETS IN DALYS AVERTED AND CYPS PSI 2014 Target: 25% increase in DALYs averted relative to Target: 30% increase in CYPs relative to Million ion DALYs averted Baseline (158.9 million DALYs averted) Performance (120.5 million DALYs averted) Million ion CYPs Provided SP Target 20 (198.7 million DALYs averted) - PSI REGIONAL AND HEALTH AREA PERFORMANCE Region YTD % of 2014 Program Target* CYPs Provided YTD Baseline (81.3 million CYPs) Strategic Plan Time Elapsed 56.7% (34/60 months) Performance (59.6 million CYPs) SP Target (105.6 million CYPs) % of 2014 Program Target* West & Central Africa 2,420,778 24,540, % 118% 516,607 4,139,413-19% 71% East Africa 1,008,322 9,831,191-5% 96% 286,172 4,603,434 32% 109% Southern Africa 1,412,431 8,125,142 16% 80% 310,976 2,968,524 6% 82% Latin America & Caribbean 16, ,003 6% 82% 74, ,900 9% 81% Asia & Eastern Europe 171,768 1,548,158-42% 46% 370,426 3,634,537-47% 45% TOTAL 5,029,385 44,186,471 41% 99% 1,559,152 16,001,809-15% 71% Health Burden Country with Program YTD Burden as % of PSI Global HIV, STD, Hepatitis B&C, Opioid Use 929,492 9,084,996 4% 51 of % 6.81% Tuberculosis 13, ,680-1% 9 of % 2.66% Reproductive Health 592,338 6,435,769-12% 52 of % 8.14% Malaria 3,435,844 27,692, of % 5.43% Diarrhea Diseases 31, ,206 12% 29 of % 5.25% Nutritional Deficiencies % 6 of % 2.33% Respiratory Infections 26, ,490-54% 5 of % 5.95% Health areas not targeted by PSI 63.41% TOTAL 5,029,385 44,186,471 41% 2.25% * 2014 program targets: 44,748,981 DALYs averted; we should be at 83% in CYPs Provided IMPACT DASHBOARD OCTOBER

2 PSI PROGRESS ON RELEVANCE SP Target Health Relevance 24.91% 42% FP Method Mix* 54.7% (29 of 53)** 75% *% platforms offering 4 or more FP modern methods with at least one long-term method (LTM), ** excluded C.A.R., China, Cote d'ivoire (AIMAS), Mexico, and Romania PSI RELEVANCE: 2010 Global Burden of Disease < Expansion & Innovation > 90% 80% 70% 60% 50% 40% 30% Current works 20% 10% 0% PSI Global Innovation in Other Health Areas: % disease burden not targeted by PSI Notes: started reporting in this period Botswana (added burden from malaria - LLIN distribution) Belize added OC and met the target in this period. DRC and Mozambique added EC. Expansion: % disease burden targeted by existing PSI products/services plus cervical cancer, diabetes mellitus, and high blood pressure, not in use by country platform Health Relevance: % disease burden targeted by current country platform products and services Burden : % DALYs averted by PSI in 2014 as proportion of 2010 Global Burden of Disease in DALYs 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Mozambique Zimbabwe Cameroon Nigeria Zambia Swaziland Madagascar Tanzania South Africa Malawi Uganda Mali Côte d'ivoire Lesotho DRC Botswana Kenya Guinea Benin Rwanda South Sudan Angola Myanmar Burundi Namibia Senegal Togo Liberia Caribbean Pakistan India Belize Cambodia Ethiopia PNG Laos Thailand Dom Rep Guatemala Honduras Viet Nam Panama Nicaragua Tajikistan Paraguay El Salvador Kyrgyzstan yzstan Nepal Haiti Kazakhstan Costa Rica Russia PSI FP Method Mix: classified by modern method mix. FP method mix targets 4 methods + 1 long-term method (LTM) 4 or more modern methods + 1 LTM 4 or more modern methods + 1 LTM 2 modern methods Congo-Kinshasa Ethiopia Papua New Guinea Madagascar Rwanda Somaliland Nigeria El Salvador South Africa Guatemala Nicaragua Swaziland Pakistan Belize Thailand Benin Haiti 1 short-term method Malawi India Botswana Mali Laos Costa Rica Mozambique Liberia Cote d'ivoire Myanmar 3 modern methods Honduras Tanzania Dominican Republic Kazakhstan Togo Nepal Panama Zimbabwe Guinea South Sudan Cambodia Paraguay Tajikistan Cameroon Senegal Vietnam Uganda 2 modern methods no FP method provided Zambia Angola Russia Caribbean Kyrgyzstan Burundi Lesotho Kenya Namibia number of long-term methods including implants, IUDs and male/female sterilization number of short-term methods including male condom, female condom, cycle beads, EC, injectables and OC IMPACT DASHBOARD OCTOBER

3 COUNTRIES BY YTD 2014 DALYS AVERTED 2014 DALYs % of 2014 DALYs Health Relevance % Congo-Kinshasa 785,207 11,232, % 149% 36.02% 20,137, % Nigeria 648,773 10,561,098 47% 109% 44.18% 25,948, % Zimbabwe 956,367 2,837,865 54% 76% 45.67% 6,276, % South Sudan 459,175 2,386,752-33% 114% 31.99% 8,984, % South Africa 239,870 2,001,085 2% 82% 42.59% 6,558, % Mali 884,475 1,830, % 72% 40.55% 4,653, % Uganda 201,922 1,758,708 68% 102% 40.64% 3,917, % Kenya 108,029 1,564,417 78% 129% 35.38% 3,703, % Zambia 0 1,353,497-14% 62% 44.16% 5,100, % Tanzania 57,063 1,238,378-13% 75% 42.64% 4,032, % Mozambique 57,702 1,075,693-29% 77% 48.88% 4,005, % Madagascar 78,478 1,027,830 13% 94% 42.82% 4,372, % Malawi 57, ,255-45% 76% 41.95% 3,796, % Pakistan 28, ,008-44% 44% 19.82% 2,644, % Angola 32, , % 129% 31.42% 1,021, % Cameroon 66, ,773 36% 92% 44.69% 1,322, % India 74, ,001-51% 35% 19.34% 2,729, % Lesotho 36, ,586 46% 154% 37.85% 949, % Myanmar 38, ,386-28% 69% 31.24% 1,319, % Ethiopia 0 284,049-9% 68% 16.37% 1,022, % Swaziland 10, ,406 24% 88% 43.23% 748, % Botswana 83, , % 316% 35.76% 398, % Benin 13, ,850 12% 86% 32.62% 591, % Rwanda 6, ,914 3% 71% 32.02% 662, % Burundi 25, ,819 33% 93% 30.09% 402, % Guinea 8, ,200-89% 82% 32.89% 1,529, % Cambodia 16, ,029-34% 63% 18.83% 706, % Togo 6,150 70,066-11% 54% 28.40% 260, % Senegal 5,219 53,127 29% 68% 29.30% 119, % Namibia 6,242 45,057-67% 53% 29.56% 210, % Guatemala 3,670 40,670 19% 83% 8.87% 130, % Haiti 4,074 34,427-2% 76% 5.01% 166, % Dominican Republic 4,634 28,979 3% 87% 9.06% 93, % Somaliland 2,110 22,668 16% 84% NA 63, % Viet Nam 4,394 19,809-42% 82% 8.17% 87, % Cote d'ivoire 1,157 17,544-26% 76% 38.99% 583, % Laos 3,379 14,929 33% 95% 13.47% 42, % Thailand 4,166 14,516-6% 85% 9.16% 41, % Nepal ,716-75% 19% 5.57% 146, % Tajikistan 94 12,542 42% 103% 7.48% 28, % Papua New Guinea 598 8,231 39% 142% 13.73% 24, % Panama 511 7,447 29% 104% 7.91% 20, % Liberia 1,738 6,986 50% 78% 21.35% 18, % Paraguay 754 6,956 4% 78% 7.00% 22, % El Salvador 807 6,613 7% 87% 6.87% 25, % Honduras 733 6,319-4% 78% 8.33% 21, % Nicaragua 540 5,818-1% 72% 7.58% 21, % Kazakhstan 16 2,952 95% 3.79% 15, % Belize 158 1,715 30% 88% 19.06% 5, % Caribbean 111 1, % 71% 20.35% 4, % Costa Rica % 70% 3.06% 3, % Kyrgyzstan % 6.49% 16, % Russia 0 0 NA NA 0.00% % PSI GLOBAL 5,029,385 44,186,471 41% 99% 24.91% 120,479,675 * 2014 program targets: 44,748,981 DALYs averted; we should be at 83% in. 11 Company 158** 84, ,796 7% NA NA 2,680, % **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD OCTOBER

4 PSI PRODUCTS & SERVICES BY YTD 2014 DALYS AVERTED 0% Products / Services 2014 DALYs % of 2014 DALYs # Distributed Reporting 2014 CYPs LLIN 1,578,896 18,549, % 119% 27,895, Malaria PPT (ACT) 1,856,890 9,135,580 37% 111% 15,801, Condom 675,043 6,506,736-10% 69% 690,586, ,754,888 Free Condom 241,089 2,561,593 15% 104% 203,085, ,692,379 Male Circumcision 69,485 1,123,378 10% 87% 311,534 9 Basic Care Package 156,324 1,060,444 56% 96% 21,446,505 2 OC 83, ,511-28% 74% 29,548, ,969,867 Injectable 3 52, ,539-7% 77% 6,160, ,540,153 IUD 10 Insertion 52, ,556 2% 108% 287, ,321,745 HIV Counseling and Testing 35, ,690-11% 74% 1,656, Implant 5 Insertion 35, ,849 30% 208% 224, ,504 Pneumonia PPT 26, ,490-54% 684,651 5 Implant 3 Distribution 15, , % 901% 238, ,448 IUD 10 Distribution 28, ,985-21% 51% 103, ,060 IUD 5 Insertion 1, ,213-19% 1074% 142, ,765 Diarrhea Treatment Kit 10, ,075 26% 69% 2,519, IUD 5 Distribution 9, ,627-71% 23% 175, ,250 ORS 10, ,455 73% 123% 3,717,821 9 TB DOTS 13, ,680-1% 85% 20,344 4 Safe Water Solution 7, ,344-31% 68% 8,224, Female Condom 15, ,891 25% 111% 8,457, ,477 Injectable 2 10,430 95,606-5% 56% 1,198, ,801 Emergency Contraception 3,416 47,215-1% 46% 2,555, ,776 Implant 3 Insertion 3,340 45,408 82% 113% 31, ,575 SDM (Cycle Beads) 2,270 42,872 4% 72% 58, ,082 Implant 5 Distribution 9,999 41,727-72% 14% 23, ,071 Needle & Syringe 4,743 29, % 91% 3,681,906 4 Water Treatment Tablets 1,725 27,343 9% 83% 55,166, STI Kit 4,290 24, % 517,162 6 Free Female Condom 1,652 21,414-32% 87% 1,595, ,296 Misoprostol for PAC (Oral) 5,896 20,526-2% 64% 1,187,785 5 Zinc 1,194 13, % 360% 1,185,213 5 Tubal Ligation 1,036 12,638-35% 21% 5, ,500 Medication Abortion 1,157 12,457-11% 75% 398,046 3 Naloxone 0 7,912-10% 80% 5,813 2 Early Infant MC 819 6,787-39% 46% PUR 655 5,999-21% 95% 38,736, Injectable ,285-24% 53% 194, ,965 Clean Delivery Kit 463 3,446-24% 67% 48,494 5 Malaria PPT (Non-ACT) 0 3,426-23% 60% 40,200 1 Retreatment IconMaxx 0 3,243-94% NA 21,519 1 Implant 4 Insertion 26 3,241 72% 13% 2, ,971 Misoprostol for PPH 449 2,977 67% 270% 643,126 3 Skilled Birth Attendance (Facility Deliv 333 2, % NA 11,258 1 LifeStraw 1, % 1020% 7,843 1 Antiretroviral Treatment (Patient-mont % 47% 1,916 1 Cervical Cancer-VIA/PAP & Cryothe % 46% 1,823 8 IPTp % 1% 8,080 1 Multivitamin % 81% 2,185,680 2 Vasectomy % 73% ,610 Implant 4 Distribution 1-1, % -180% -1,366 1 (4,371) Iron Folic Acid Tablet NA 0 Malaria RDK 0 0 NA NA 5,152, Micronutrient Powder 0 0 NA NA 1,927,420 3 PSI GLOBAL 5,029,385 44,186,471 41% 99% 16,001,809 * 2014 program targets: 44,748,981 DALYs averted; we should be at 83% in. IMPACT DASHBOARD OCTOBER

5 COUNTRIES BY YTD 2014 CYPS PROVIDED ## 2014 CYPs CYPs % of 2014 CYPs FP Method Mix CYPs Provided % of CYPs Provided Nigeria 295,292 2,806,160 7% 75% 9,254, % Kenya 125,508 1,870, % 159% 3,895, % Pakistan 72,314 1,653,652-46% 42% 7,390, % Tanzania 62,867 1,147,752-19% 75% 3,999, % South Africa 130,268 1,061,311 0% 81% 3,524, % India 176, ,690-59% 36% 7,161, % Madagascar 84, ,382 10% 92% 2,807, % Uganda 53, ,129 67% 142% 2,092, % Cambodia 39, ,161-12% 62% 2,025, % Myanmar 56, ,896-32% 80% 1,735, % Mali 70, ,531-58% 58% 1,546, % Zambia 352,199-23% 51% 1,499, % Cameroon 86, ,058 39% 85% 975, % Zimbabwe 31, ,295 34% 79% 901, % Benin 17, ,022 5% 88% 761, % Ethiopia 0 202,103-10% 69% 721, % Guatemala 17, ,393 26% 83% 628, % Malawi 15, ,686 22% 132% 459, % Lesotho 17, ,418 53% 168% 419, % Mozambique 18, ,177 18% 63% 502, % Congo-Kinshasa 22, ,633-73% 32% 1,438, % Dominican Republic 18, ,617 3% 87% 371, % Botswana 42, , % 316% 203, % Guinea 7, ,701 2% 72% 408, % Haiti 12, ,956 1% 74% 336, % Rwanda 3,833 99,009 3% 70% 345, % Togo 7,165 86,247-44% 56% 432, % Paraguay 7,524 69,890 4% 79% 226, % Senegal 7,826 65,636-12% 60% 212, % Swaziland ,954 45% 109% 169, % Laos 20,788 56,040 44% 102% 150, % Nicaragua 4,947 54,086-1% 70% 205, % El Salvador 7,466 44,868 5% 93% 191, % Burundi 3,940 42,737 20% 76% 104, % Angola 1,730 34,543 28% 95% 136, % Panama 2,089 30,027 29% 104% 81, % Nepal ,349-81% 14% 422, % Namibia 3,437 24,821-66% 54% 114, % Honduras 2,886 24,806-4% 78% 85, % Thailand 4,322 12,200-3% 97% 32, % Costa Rica 864 7,740-8% 65% 27, % Cote d'ivoire 746 5,974-34% 142% 17, % Liberia 346 5,452 40% 59% 16, % South Sudan 0 4,452-79% NA 67, % Tajikistan 85 4,087 10% 65% 10, % Papua New Guinea 688 4,064 3% 88% 18, % Caribbean 314 3, % 69% 14, % Somaliland 253 2,336 16% 89% 7, % Belize 178 1,816 27% 92% 5, % Kazakhstan % 116% % Kyrgyzstan % 98% 37, % Viet Nam % 169, % Russia 0 0 NA NA 0 0.0% PSI GLOBAL 1,559,152 16,001,809-15% 55% 59,560,032 * 2014 program targets: 22,655,582 CYPs; we should be at 83% in. Company 158** 48, ,368 7% NA 1,540, % **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD OCTOBER